title: [Two Year Recurrence Free Survival after Resection of Cutaneous Metastasis from Pancreatic Cancer - A Case Report].
abstract: The patient was a 73-year-old woman who underwent distalpancreatectomy for pancreas tailcancer (T3, N0, M0, stage III ). Hepatic arterialinfusion(HAI)using high-dose 5-fluorouracil(5-FU)(6,000mg/week)was performed 35 days after curative resection to prevent liver metastases. Although chemotherapy with gemcitabine(GEM)was administered for 2 weeks, the patient was aware of a nodule(1 cm in diameter)on the right lower quadrant of the abdomen. Resection of the cutaneous mass was performed and histological findings revealed metastatic adenocarcinoma from the pancreas cancer. Six courses of chemotherapy with GEM were administered as adjuvant therapy. Two years after the treatment with GEM, neurological symptoms appeared, and computed tomography(CT)and magnetic resonance imaging(MRI)revealed a solitary metastatic thalamus tumor(2 cm in diameter). After stereotactic radiotherapy, the patient was transferred to a different hospitalfor physicaltherapy. Herein, we report on a case of 2 year recurrence free survivalafter the resection of a cutaneous metastasis from pancreatic cancer.
authors.affiliation: Dept. of Gastroenterological Surgery, Iseikai Hospital.
authors.forename: Takahiko
authors.initials: T
authors.lastname: Tanigawa
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Hasuike
authors.forename: Yousuke
authors.initials: Y
authors.lastname: Akiyama
authors.forename: Ichiro
authors.initials: I
authors.lastname: Higuchi
authors.forename: Akira
authors.initials: A
authors.lastname: Ishikawa
authors.forename: Sanae
authors.initials: S
authors.lastname: Hosomi
authors.forename: Makoto
authors.initials: M
authors.lastname: Miyamoto
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary* / Q000628:therapy*; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000532:radiotherapy / Q000556:secondary; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010190:Pancreatic Neoplasms / Q000473:pathology* / Q000628:therapy*; D012008:Recurrence; D012878:Skin Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D013788:Thalamus / Q000473:pathology; D013997:Time Factors; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine